My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 127

    1.

    Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks.

    Kolaczynski JW, Caro JF.

    Ann Intern Med. 1994 Jan 1;120(1):47-55. Review.PMID: 8250456 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.

    Ranke MB.

    Trends Endocrinol Metab. 2005 May-Jun;16(4):190-7. Review.PMID: 15860416 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical uses of insulin-like growth factor I.

    Bondy CA, Underwood LE, Clemmons DR, Guler HP, Bach MA, Skarulis M.

    Ann Intern Med. 1994 Apr 1;120(7):593-601. Review.PMID: 8116999 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The IGF system in metabolism regulation.

    Binoux M.

    Diabete Metab. 1995 Dec;21(5):330-7. Review.PMID: 8586149 [PubMed - indexed for MEDLINE]Related articles

    5.

    The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.

    Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J.

    J Clin Endocrinol Metab. 2000 Apr;85(4):1518-24.PMID: 10770191 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Therapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitus.

    Mohamed-Ali V, Pinkney J.

    Treat Endocrinol. 2002;1(6):399-410. Review.PMID: 15832492 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metabolic and therapeutic effects of insulin-like growth factor I.

    Froesch ER, Zenobi PD, Hussain M.

    Horm Res. 1994;42(1-2):66-71. Review.PMID: 7959637 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility.

    Thrailkill KM.

    Diabetes Technol Ther. 2000 Spring;2(1):69-80. Review.PMID: 11467325 [PubMed - indexed for MEDLINE]Related articles

    9.

    The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis.

    Holt RI, Simpson HL, Sönksen PH.

    Diabet Med. 2003 Jan;20(1):3-15. Review.PMID: 12519314 [PubMed - indexed for MEDLINE]Related articles

    10.

    Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.

    Johnson MD, Campbell LK, Campbell RK.

    Ann Pharmacother. 1998 Mar;32(3):337-48. Review.PMID: 9533065 [PubMed - indexed for MEDLINE]Related articles

    11.

    Recombinant human insulin-like growth factor-I: a therapeutic challenge for diabetes mellitus.

    Froesch ER, Hussain M.

    Diabetologia. 1994 Sep;37 Suppl 2:S179-85. Review.PMID: 7821734 [PubMed - indexed for MEDLINE]Related articles

    12.

    Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus.

    Vestergaard H, Rossen M, Urhammer SA, Müller J, Pedersen O.

    Eur J Endocrinol. 1997 May;136(5):475-82.PMID: 9186267 [PubMed - indexed for MEDLINE]Related articles

    13.

    Insulin-like growth factor-I and diabetes. A review.

    Simpson HL, Umpleby AM, Russell-Jones DL.

    Growth Horm IGF Res. 1998 Apr;8(2):83-95. Review.PMID: 10987675 [PubMed - indexed for MEDLINE]Related articles

    14.

    Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?

    Orskov H.

    Metabolism. 1996 Aug;45(8 Suppl 1):91-5. Review.PMID: 8769394 [PubMed - indexed for MEDLINE]Related articles

    15.

    Atypical antipsychotics and glucose homeostasis.

    Bergman RN, Ader M.

    J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.PMID: 15816794 [PubMed - indexed for MEDLINE]Related articles

    16.

    Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients.

    Jabri N, Schalch DS, Schwartz SL, Fischer JS, Kipnes MS, Radnik BJ, Turman NJ, Marcsisin VS, Guler HP.

    Diabetes. 1994 Mar;43(3):369-74.PMID: 8314009 [PubMed - indexed for MEDLINE]Related articles

    17.

    Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes.

    Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR.

    Diabetes. 1996 Jan;45(1):91-100.PMID: 8522066 [PubMed - indexed for MEDLINE]Related articles

    18.

    Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.

    Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL.

    Clin Endocrinol (Oxf). 1998 Dec;49(6):739-46.PMID: 10209561 [PubMed - indexed for MEDLINE]Related articles

    19.

    Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus.

    Dunger DB, Cheetham TD.

    Horm Res. 1996 Jul;46(1):2-6. Review.PMID: 8854134 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance.

    Froesch ER, Bianda T, Hussain MA.

    Diabetes Metab. 1996 Jul;22(4):261-7. Review.PMID: 8767173 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity